Boehringer Ingelheim Venture Fund

United States
Firm Location:United States • Connecticut • San Francisco, California • Cambridge, Massachusetts • Hong Kong • Shanghai • San Francisco Bay Area • Germany
Boehringer Ingelheim Venture Fund Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany
n/a
$8.5M
($3.3M - $17.0M)
Investors in San Francisco (CA)
n/a
$8.5M
($3.3M - $17.0M)
Investors in Israel, Investors in Europe
+17
n/a
$8.5M
($3.3M - $17.0M)
Investors in Hong Kong
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany
Investors in BioTech (Series B)
n/a
$8.5M
($3.3M - $17.0M)
Investors in United States
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany
n/a
$8.5M
($3.3M - $17.0M)
Investors in Shanghai
n/a
$1.5M
($100K - $5.0M)
Investors in Boston (MA)
+18
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A)
n/a
$8.5M
($3.3M - $17.0M)
Investors in San Francisco (CA)
n/a
$8.5M
($3.3M - $17.0M)
Investors in Boston (MA)
+18
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany
n/a
$8.5M
($3.3M - $17.0M)
Investors in Cambridge (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists)
+5
n/a
$8.5M
($3.3M - $17.0M)
Investors in Germany